| 000 | 01622 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514220914.0 | ||
| 264 | 0 | _c20050503 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/j.ejca.2004.12.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBos, A M E | |
| 245 | 0 | 0 |
_aA phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMar 2005 |
||
| 300 |
_a539-48 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDe Vos, F Y F L | |
| 700 | 1 | _ade Vries, E G E | |
| 700 | 1 | _aBeijnen, J H | |
| 700 | 1 | _aRosing, H | |
| 700 | 1 | _aMourits, M J E | |
| 700 | 1 | _avan der Zee, A G J | |
| 700 | 1 | _aGietema, J A | |
| 700 | 1 | _aWillemse, P H B | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 41 _gno. 4 _gp. 539-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2004.12.003 _zAvailable from publisher's website |
| 999 |
_c15411740 _d15411740 |
||